Pfizer

New Products: BPH surgical robot granted FDA de novo requestOther products highlighted in this round-up include a plate for studying infections caused by the long-term use of catheters and a new indication for sunitinib malate (SUTENT).
Pfizer VP Robert Popovian Talks Value-Based ReimbursementThe impact of VBRs on outcomes, VBRs versus other healthcare reimbursement initiatives, and VBR successes and failures. Pfizer’s Robert Popovian, PharmD, weighs in.
Every New FDA Drug Approval in 2017
Every New FDA Drug Approval in 2017The last 12 drugs approved in the year, along with the other 34.
Top 5 pipeline drugs for 2018
Top 5 pipeline drugs for 2018New blockbuster drugs to treat various conditions are expected to be among the top drugs to hit the marketplace in 2018. Here are 5 of the top new drugs in the pipeline for 2018, according to analysts.
Pfizer won't launch its second Remicade biosimilar in U.S.
Generic Viagra Could Save Patients MillionsBoth Pfizer and Teva have brought out generic versions of Viagra, a boon to the millions of men with erectile dysfunction.
How generic cyclosporine might affect optometry
How generic cyclosporine might affect optometryI foresee every dry eye script I write to be “changed” to generic cyclosporine. This means optometrists will be straddled with more burdensome prior authorizations and delays for the patients.
FDA warns Pfizer’s Meridian over EpiPen flawsFDA warned about an injunction or seizure if Meridian Medical Technologies, a division of Pfizer, does not correct its problems with the EpiPen (epinephrine auto-injector).
FDA Sends Warning Letter to EpiPen Manufacturer
FDA Sends Warning Letter to EpiPen ManufacturerEpiPen manufacturer is accused of lax investigation into problems.
New universal companion diagnostic paves the way for precision oncologyFDA approves new diagnostic test for non-small cell lung cancer.